Myocarditis in a Patient on Clozapine: What did it?

Area of Science:

• Psychiatry
• Cardiology
• Infectious Diseases

Background:

• Clozapine is a critical treatment for treatment-resistant psychosis, particularly in schizoaffective disorder.
• Myocarditis is a known, albeit rare, side effect of clozapine therapy.
• Influenza A infection can also cause myocarditis.

Observation:

• A 37-year-old male with treatment-resistant schizoaffective disorder developed myocarditis within three weeks of initiating clozapine.
• The patient concurrently tested positive for Influenza A, presenting a diagnostic challenge.
• The etiology of the myocarditis was unclear, potentially due to influenza, clozapine, or a synergistic effect.

Findings:

• This case presents a diagnostic dilemma regarding the cause of myocarditis in a patient on clozapine with concurrent influenza infection.
• No prior studies have established a direct link between influenza and clozapine-induced myocarditis.
• The possibility of a synergistic interaction between clozapine and influenza exacerbating myocarditis is considered.

Implications:

• Understanding the interplay between clozapine and viral infections like influenza is crucial for managing patients with psychiatric disorders.
• Further research is needed to elucidate the potential synergistic cardiotoxic effects.
• This case underscores the importance of vigilant cardiac monitoring in patients initiating clozapine, especially during periods of increased infectious disease prevalence.